Novo Integrated Sciences, Inc.
NVOS
$0.065
$0.009316.70%
| Weiss Ratings | NVOS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | NVOS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | NVOS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -1.76 | |||
| Price History | NVOS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 8.33% | |||
| 30-Day Total Return | -7.28% | |||
| 60-Day Total Return | 47.73% | |||
| 90-Day Total Return | -70.72% | |||
| Year to Date Total Return | 28.97% | |||
| 1-Year Total Return | -89.68% | |||
| 2-Year Total Return | -96.80% | |||
| 3-Year Total Return | -99.60% | |||
| 5-Year Total Return | -99.80% | |||
| 52-Week High % Change | -96.05% | |||
| 52-Week Low % Change | 106.30% | |||
| Price | NVOS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.41 | |||
| 52-Week Low Price | $0.03 | |||
| 52-Week Low Price (Date) | Nov 08, 2024 | |||
| 52-Week High Price (Date) | May 31, 2024 | |||
| Valuation | NVOS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.10M | |||
| Enterprise Value | 5.96M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.91 | |||
| Earnings Per Share Growth | -55.92% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.08 | |||
| Price/Book (Q) | 0.07 | |||
| Enterprise Value/Revenue (TTM) | 0.45 | |||
| Price | $0.07 | |||
| Enterprise Value/EBITDA (TTM) | -0.98 | |||
| Enterprise Value/EBIT | -0.72 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | NVOS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 19.06M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | NVOS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 206 617 9797 | |||
| Address | 11120 NE 2nd Street Bellevue, WA 98004 | |||
| Website | www.novointegrated.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | NVOS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -62.53% | |||
| Profit Margin | -121.60% | |||
| Management Effectiveness | NVOS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -15.35% | |||
| Return on Equity | -- | |||
| Income Statement | NVOS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 13.29M | |||
| Total Revenue (TTM) | 13.29M | |||
| Revenue Per Share | $0.70 | |||
| Gross Profit (TTM) | 5.74M | |||
| EBITDA (TTM) | -6.05M | |||
| EBIT (TTM) | -8.31M | |||
| Net Income (TTM) | -16.17M | |||
| Net Income Avl. to Common (TTM) | -16.17M | |||
| Total Revenue Growth (Q YOY) | -6.74% | |||
| Earnings Growth (Q YOY) | 256.57% | |||
| EPS Diluted (TTM) | -0.91 | |||
| EPS Diluted Growth (Q YOY) | 223.83% | |||
| Balance Sheet | NVOS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 844.60K | |||
| Cash Per Share (Q) | $0.04 | |||
| Total Current Assets (Q) | 5.41M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 14.61M | |||
| Current Ratio (Q) | 0.371 | |||
| Book Value Per Share (Q) | $0.78 | |||
| Total Assets (Q) | 32.14M | |||
| Total Current Liabilities (Q) | 14.58M | |||
| Total Debt (Q) | 5.98M | |||
| Total Liabilities (Q) | 17.53M | |||
| Total Common Equity (Q) | 14.89M | |||
| Cash Flow | NVOS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -5.00K | |||
| Cash from Financing (TTM) | 4.99M | |||
| Net Change in Cash (TTM) | 428.20K | |||
| Levered Free Cash Flow (TTM) | 4.67M | |||
| Cash from Operations (TTM) | -5.07M | |||
